Wu, Xiaoyun <br/><br/>
A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin  [electronic resource] 

 -  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy  Jun 2019 
 - 335-342 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1179-190X 
<br/><br/><label>Standard No.: </label>10.1007/s40259-019-00352-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Area Under Curve<br/>Bevacizumab--pharmacokinetics<br/>Biosimilar Pharmaceuticals--pharmacokinetics<br/>Double-Blind Method<br/>Healthy Volunteers<br/>Humans<br/>Infusions, Intravenous--methods<br/>Male<br/>Plasma--metabolism<br/>Therapeutic Equivalency<br/>Young Adult